Senior Vice Principal, Strategic Partnerships (Fully Remote)

Evotec; United States; Remote; USD 180,000 - 260,000; Full time

Job summary

Evotec in the United States seeks a senior leader to shape and execute its next-generation strategic innovation partnerships. You will design and drive long-term alliances with pharma, biotech and ecosystem partners, aligning science, legal, finance and operations to maximize portfolio value.

The role requires a proven track record closing innovation-driven partnerships, a Masters/MBA, and 15+ years in biopharma, with a global network across senior industry leadership.

Qualifications

• Masters/MBA or equivalent required.
• 15+ years in biopharma or related field.
• Track record of closing innovation-driven partnerships.
• Strong scientific credibility and global senior leadership network.

Responsibilities

• Shape and execute Evotec's next-generation strategic innovation partnerships.
• Design long-term alliances with pharma, biotechs, and ecosystem partners.
• Structure complex platform deals and lead C-suite negotiations.
• Align scientific, legal, finance, and operational functions to optimize portfolio value.

Skills

Deals/partnership closing

C-suite negotiations

Strategic partnerships

Global network

Education

Masters/MBA

Job description

• Shape and execute Evotec's next-generation strategic innovation partnerships.
• Design long-term alliances with pharma, biotechs, and ecosystem partners.

Key Responsibilities:

• Structure complex platform deals and lead C-suite negotiations.
• Align scientific, legal, finance, and operational functions to optimize portfolio value.

Experience Required:

• Track record in closing innovation-driven partnerships; Masters/MBA plus 15+ years in biopharma.
• Deep scientific credibility and global network across senior industry leadership.

Evotec

Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The company focuses on building best-in-class differentiated therapeutics and forming science-driven discovery alliances with pharmaceutical and biotechnology companies.